Cardiovascular Research Foundation competitors

James Fairbairn has 20+ years in senior finance roles with emerging companies. He is a Chartered Professional Accountant, having obtained his CPA designation in 1987 and is an Institute-certified Director. Jim holds a Bachelor of Arts from the University of Western Ontario. He is a director of several junior listed companies.

Jonathan Waldstreicher, Principal, joined Apple Tree Partners in 2013 to invest in medical devices. After incubating an interventional pulmonary technology for two years, Jon founded Gala Therapeutics in Silicon Valley and assumed the CEO role to further its development. Prior to joining ATP, Jon was a Director, Global Surgery R&D, at Johnson & Johnson where he initiated and led an investment strategy and R&D development program in a new growth platform technology area. He started at Johnson & Johnson as an Associate Director in the Corporate Office of Science & Technology where he executed numerous seed grants to startup companies and participated in technical diligence of venture capital investments. Before medical school, Jon worked in Equity Research at Bear Stearns. Jon received a B.A. from Brandeis University in Economics and an MD and MBA from Tufts University School of Medicine where he was awarded the Norman Stearns award for highest achievement and overall excellence within the dual degree program. He completed a General Surgery Internship at Tufts Medical Center in Boston.

John Culin E. is a Chief Executive Officer at Synergy Enterprises Inc. and is based in United States.